Patrick Dolezal

Stock Analyst at LifeSci Capital

(2.62)
# 2,032
Out of 5,111 analysts
2
Total ratings
100%
Success rate
41.55%
Average return

Stocks Rated by Patrick Dolezal

Kodiak Sciences
Oct 23, 2025
Initiates: Outperform
Price Target: $40
Current: $24.13
Upside: +65.77%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Outperform
Price Target: $17$26
Current: $21.37
Upside: +21.67%